Autophagy potential of polyphenols in breast carcinoma: A systematic review

Asal Golchin1, Shirin Teymori Nobari2, Masomeh Maleki3

  • 1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

Insights

Polyphenols show promise in inducing autophagy for breast cancer treatment in lab studies. However, translating these findings to effective clinical outcomes remains a significant challenge.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Breast cancer remains a leading cause of mortality worldwide.
  • Autophagy, a cellular degradation process, plays a complex role in cancer progression.
  • Polyphenols are natural compounds with potential anti-cancer properties.

Purpose of the Study:

  • To systematically review the existing literature on the role of polyphenols in modulating autophagy in breast cancer.
  • To identify specific polyphenols and their mechanisms of action in breast cancer cells.
  • To assess the translational potential of polyphenol-induced autophagy for breast cancer therapy.

Main Methods:

  • A comprehensive systematic search of multiple electronic databases (PubMed, Web of Science, Scopus, EMBASE, Google Scholar) was conducted up to January 1, 2025.
  • Keywords included "Breast Cancer," "polyphenols," and "Autophagy," utilizing Medical Subject Headings (MeSH).
  • The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Main Results:

  • Curcumin modulated the PI3K/AKT/mTOR pathway, enhancing autophagic flux and reducing breast cancer cell viability in vitro.
  • Resveratrol targeted the AMPK/mTOR signaling axis, suppressing cancer stem-like cells and inhibiting tumor growth in vivo.
  • Carnosol induced autophagy, inhibited metastasis, and reduced tumor growth by degrading STAT3 and downregulating p62.

Conclusions:

  • Polyphenols demonstrate significant potential in inducing autophagy within controlled in vitro breast cancer models.
  • Translating these in vitro findings to in vivo efficacy and subsequent clinical benefits presents considerable challenges.
  • Further research is needed to bridge the gap between laboratory observations and clinical applications of polyphenol-based autophagy modulation in breast cancer.